Frazier Life Sciences Management, L.P. Diversified Active

Location: Palo Alto, CA

CIK: 0001892134 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 7, 2023

Total Value: $1.608B (100.0% shares, 0.0% debt)

Holdings (44)

HILLEVAX INC 10.2%
Value $163M Shares 9,758,359 Est. Cost $11.23 Unrealized
IMAGO BIOSCIENCES INC 8.9%
Value $143M Shares 3,987,207 Est. Cost $23.52 Unrealized
ARQT ARCUTIS BIOTHERAPEUTICS INC 8.0%
Value $129M Shares 8,684,232 Est. Cost $17.08 Unrealized +2.3%
CHINOOK THERAPEUTICS INC 7.1%
Value $114M Shares 4,345,559 Est. Cost $17.28 Unrealized
NAMS NEWAMSTERDAM PHARMA COMPANY 6.3%
Value $102M Shares 9,341,551 Est. Cost $9.95 Unrealized 0.0%
SNDX SYNDAX PHARMACEUTICALS INC 5.9%
Value $94.39M Shares 3,708,838 Est. Cost $17.68 Unrealized +31.9%
PHAT PHATHOM PHARMACEUTICALS INC 5.9%
Value $94.33M Shares 8,407,152 Est. Cost $14.12 Unrealized -27.0%
KRYS KRYSTAL BIOTECH INC 4.9%
Value $79.2M Shares 999,737 Est. Cost $62.37 Unrealized +19.0%
MIRM MIRUM PHARMACEUTICALS INC 4.7%
Value $75.27M Shares 3,860,107 Est. Cost $20.65 Unrealized -4.3%
VERONA PHARMA PLC 4.6%
Value $73.57M Shares 2,815,720 Est. Cost $14.27 Unrealized
PCVX VAXCYTE INC 4.2%
Value $67.01M Shares 1,397,405 Est. Cost $21.85 Unrealized +79.6%
RYTM RHYTHM PHARMACEUTICALS INC 3.4%
Value $55.15M Shares 1,894,000 Est. Cost $18.60 Unrealized +38.2%
ALLAKOS INC 2.5%
Value $40.35M Shares 4,792,000 Est. Cost $6.12 Unrealized
ANAB ANAPTYSBIO INC 1.7%
Value $27.88M Shares 899,700 Est. Cost $30.26 Unrealized -6.7%
TARS TARSUS PHARMACEUTICALS INC 1.6%
Value $26.21M Shares 1,787,527 Est. Cost $17.82 Unrealized -7.2%
CRNX CRINETICS PHARMACEUTICALS IN 1.6%
Value $25.89M Shares 1,414,823 Est. Cost $20.24 Unrealized -12.9%
REPL REPLIMUNE GROUP INC 1.6%
Value $25.34M Shares 931,560 Est. Cost $18.89 Unrealized +10.0%
COGT COGENT BIOSCIENCES INC 1.5%
Value $24.38M Shares 2,109,154 Est. Cost $7.05 Unrealized +75.7%
ALPINE IMMUNE SCIENCES INC 1.4%
Value $21.95M Shares 2,985,757 Est. Cost $8.97 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 1.4%
Value $21.89M Shares 3,238,859 Est. Cost $9.73 Unrealized -45.0%
GRITSTONE BIO INC 1.1%
Value $17.81M Shares 5,162,348 Est. Cost $4.12 Unrealized
SUTRO BIOPHARMA INC 0.9%
Value $14.35M Shares 1,776,479 Est. Cost $8.22 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 0.8%
Value $13.65M Shares 857,338 Est. Cost $16.19 Unrealized -3.5%
SLN SILENCE THERAPEUTICS PLC 0.8%
Value $13.44M Shares 881,173 Est. Cost $19.00 Unrealized
TRVI TREVI THERAPEUTICS INC 0.8%
Value $12.86M Shares 6,663,590 Est. Cost $2.89 Unrealized -31.7%
CEREVEL THERAPEUTICS HLDNG I 0.8%
Value $12.4M Shares 393,000 Est. Cost $28.54 Unrealized
MERUS N V 0.7%
Value $11.55M Shares 746,479 Est. Cost $25.59 Unrealized
VECTIVBIO HLDG AG 0.7%
Value $11.48M Shares 1,333,400 Est. Cost $8.61 Unrealized
RNAM AVIDITY BIOSCIENCES INC 0.7%
Value $11.1M Shares 500,000 Est. Cost $14.91 Unrealized 0.0%
IMVT IMMUNOVANT INC 0.6%
Value $10.4M Shares 585,759 Est. Cost $6.23 Unrealized +102.2%
TYRA TYRA BIOSCIENCES INC 0.6%
Value $10.09M Shares 1,327,665 Est. Cost $11.74 Unrealized -39.7%
BLUEBIRD BIO INC 0.6%
Value $9.97M Shares 1,440,757 Est. Cost $6.33 Unrealized
ARVN ARVINAS INC 0.6%
Value $9.761M Shares 285,331 Est. Cost $67.21 Unrealized -37.4%
PRTA PROTHENA CORP PLC 0.5%
Value $7.706M Shares 127,900 Est. Cost $58.56 Unrealized 0.0%
AUTL AUTOLUS THERAPEUTICS PLC 0.4%
Value $7.119M Shares 3,746,857 Est. Cost $4.17 Unrealized
NTLA INTELLIA THERAPEUTICS INC 0.4%
Value $7.107M Shares 203,684 Est. Cost $84.72 Unrealized -43.9%
THESEUS PHARMACEUTICALS INC 0.4%
Value $6.963M Shares 1,398,194 Est. Cost $4.98 Unrealized
PASSAGE BIO INC 0.3%
Value $5.185M Shares 3,756,915 Est. Cost $3.10 Unrealized
ZYME ZYMEWORKS DEL INC 0.3%
Value $4.795M Shares 610,000 Est. Cost $7.03 Unrealized 0.0%
ACRS ACLARIS THERAPEUTICS INC 0.3%
Value $4.57M Shares 290,189 Est. Cost $13.64 Unrealized +17.9%
ESSA PHARMA INC 0.1%
Value $1.525M Shares 605,141 Est. Cost $6.18 Unrealized
APTINYX INC 0.0%
Value $537K Shares 1,883,244 Est. Cost $2.27 Unrealized
NAMSW NEWAMSTERDAM PHARMA COMPANY 0.0%
Value $434K Shares 500,333 Est. Cost $0.87 Unrealized
NBRVF NABRIVA THERAPEUTICS PLC 0.0%
Value $32,177 Shares 17,025 Est. Cost $4.21 Unrealized -47.6%